Posted by Michael Wonder on 27 May 2018
New drug to treat chronic lung disease has price slashed
27 May 2018 - More than half-a-million Australians with severe breathing difficulties from chronic lung disease will have the price of a life-changing drug slashed.
The Turnbull government is listing inhaler Trelegy on the PBS for those with moderate-to-severe obstructive pulmonary disease.
It will mean instead of paying $1200 per year, patients will pay a maximum $39.50 per script from Friday.
